SYNMF (Synthetic MR AB) Cyclically Adjusted Revenue per Share: $0.28 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SYNMF Synthetic MR AB SYNMF
63 GF Score
Price $0.19
GF Value $1.41
! 3 Warning Signs
View Full Analysis

What is Synthetic MR AB Cyclically Adjusted Revenue per Share?

Synthetic MR AB SYNMF 63 Cyclically Adjusted Revenue per Share is $0.28 as of Mar. 2026. GuruFocus rates SYNMF with a GF Score™ of 63/100 and a GF Value™ of $1.41. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Synthetic MR AB's adjusted revenue per share for the three months ended in Mar. 2026 was $0.019. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Synthetic MR AB's average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-15), Synthetic MR AB's current stock price is $0.1864. Synthetic MR AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $0.28. Synthetic MR AB's Cyclically Adjusted PS Ratio of today is 0.67.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Synthetic MR AB was 21.02. The lowest was 0.47. And the median was 2.87.


Synthetic MR AB  (OTCPK:SYNMF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Synthetic MR AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.1864/0.28
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Synthetic MR AB was 21.02. The lowest was 0.47. And the median was 2.87.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Synthetic MR AB Cyclically Adjusted Revenue per Share Related Terms


Synthetic MR AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Synthetic MR AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synthetic MR AB Cyclically Adjusted Revenue per Share Chart

Synthetic MR AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 7.70 0.19

Synthetic MR AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.70 9.66 13.95 0.19 0.28

SYNMF vs VEEV, BTSG, TEM: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, Synthetic MR AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's Cyclically Adjusted PS Ratio falls into.


SYNMF
63GF Score
Synthetic MR AB SYNMF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synthetic MR AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Synthetic MR AB's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.019/133.5600*133.5600
=0.019

Current CPI (Mar. 2026) = 133.5600.

Synthetic MR AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.009 101.019 0.012
201609 0.009 101.138 0.012
201612 0.021 102.022 0.027
201703 0.022 102.022 0.029
201706 0.014 102.752 0.018
201709 0.021 103.279 0.027
201712 0.034 103.793 0.044
201803 0.028 103.962 0.036
201806 0.027 104.875 0.034
201809 0.027 105.679 0.034
201812 0.037 105.912 0.047
201903 0.024 105.886 0.030
201906 0.030 106.742 0.038
201909 0.027 107.214 0.034
201912 0.024 107.766 0.030
202003 0.028 106.563 0.035
202006 0.023 107.498 0.029
202009 0.026 107.635 0.032
202012 0.041 108.296 0.051
202103 0.037 108.360 0.046
202106 0.029 108.928 0.036
202109 0.034 110.338 0.041
202112 0.044 112.486 0.052
202203 0.022 114.825 0.026
202206 0.040 118.384 0.045
202209 0.037 122.296 0.040
202212 0.041 126.365 0.043
202303 0.032 127.042 0.034
202306 0.041 129.407 0.042
202309 0.041 130.224 0.042
202312 0.065 131.912 0.066
202403 0.038 132.205 0.038
202406 0.025 132.716 0.025
202409 0.026 132.304 0.026
202412 0.026 132.987 0.026
202503 0.026 132.825 0.026
202506 0.024 133.699 0.024
202509 0.021 133.480 0.021
202512 0.030 133.390 0.030
202603 0.019 133.560 0.019

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.28 mean?
Synthetic MR AB (SYNMF) has a Cyclically Adjusted Revenue per Share of $0.28 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Synthetic MR AB and its competitors.
Is Synthetic MR AB's Cyclically Adjusted Revenue per Share too high?
Synthetic MR AB's current Cyclically Adjusted Revenue per Share is $0.28. Overall, Synthetic MR AB has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's Cyclically Adjusted Revenue per Share compare to VEEV and BTSG?
Synthetic MR AB's Cyclically Adjusted Revenue per Share of $0.28 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Synthetic MR AB and its competitors. Synthetic MR AB's current Cyclically Adjusted Revenue per Share is $0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Synthetic MR AB (SYNMF) has a current Cyclically Adjusted Revenue per Share of $0.28. The stock's GF Value™ is $1.41, compared to a current price of $0.19 — trading 86.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.28. Synthetic MR AB's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Synthetic MR AB (SYNMF), the current Cyclically Adjusted Revenue per Share is $0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synthetic MR AB (SYNMF) Overvalued in 2026?

Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued. The current stock price of $0.19 is trading 86.8% below its estimated GF Value™ of $1.41.

Key valuation signals for SYNMF:

  • Cyclically Adjusted Revenue per Share: $0.28
  • GF Value™: $1.41 vs. price of $0.19 (86.8% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the SYNMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synthetic MR AB Business Description

Other Exchanges SYNT:Sweden9480:Germany
Address Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
63GF Score

Get the complete analysis for SYNMF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.19
Price
$1.41
GF Value